Thakarakkattil Narayanan Nair Anand

Thakarakkattil Narayanan Nair Anand

Auto-generated profile, based on publicly available information

Thakarakkattil Narayanan Nair Anand

Population Health and Genomics, School of Medicine, University of Dundee, UK

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Journal of Clinical Lipidology
Verified
Journal Article
Open access
TAT.N. Anand
T.N. Anand
LJLinju M. Joseph
Linju M. Joseph
AGA.V. Geetha
A.V. Geetha
JCJoyita Chowdhury
Joyita Chowdhury
DPDorairaj Prabhakaran
Dorairaj Prabhakaran
PJPanniyammakal Jeemon
Panniyammakal Jeemon
One of the potential strategies to improve health care delivery in understaffed low- and middle-income countries (LMICs) is task sharing, where specific tasks are transferred from more qualified health care cadre to a lesser trained cadre. Dyslipidemia is a major risk factor for cardiovascular disease but often it is not managed appropriately. We conducted a systematic review with the objective to identify and evaluate the effect of task sharing interventions on dyslipidemia in LMICs. Published studies (randomized controlled trials and observational studies) were identified via electronic databases such as PubMed, Embase, Cochrane Library, PsycINFO, and CINAHL. We searched the databases from inception to September 2016 and updated till 30 June 2017, using search terms related to task shifting, and cardiovascular disease prevention in LMICs. All eligible studies were summarized narratively, and potential studies were grouped for meta-analysis. Although our search yielded 2938 records initially and another 1628 in the updated search, only 15 studies met the eligibility criteria. Most of the studies targeted lifestyle modification and care coordination by involving nurses or allied health workers. Eight randomized controlled trials were included in the meta-analysis. Task sharing intervention were effective in lowering low-density lipoprotein cholesterol (-6.90 mg/dL; 95% CI -11.81 to -1.99) and total cholesterol (-9.44 mg/dL; 95% CI -17.94 to -0.93) levels with modest effect size. However, there were no major differences in high-density lipoprotein cholesterol (-0.29 mg/dL; 95% CI -0.88 to 1.47) and triglycerides (-14.31 mg/dL; 95% CI -33.32 to 4.69). The overall quality of evidence based on Grading of Recommendations Assessment, Development and Evaluation was either "low" or "very low". Available data are not adequate to make recommendations on the role of task sharing strategies for the management of dyslipidemia in LMICs. However, the studies conducted in LMICs demonstrate the potential use of this strategy especially in terms of reduction in low-density lipoprotein cholesterol and total cholesterol levels. Our review calls for the need of well-designed and large-scale studies to demonstrate the effect of task-sharing strategy on lipid management in LMICs.

7 January 2020 in Endocrinology, Diabetes & Metabolism
Verified
Journal Article
Open access
PDF file
ANAnand Thakarakkattil Narayanan Nair
Anand Thakarakkattil Narayanan Nair
LDLouise A. Donnelly
Louise A. Donnelly
ADAdem Y. Dawed
Adem Y. Dawed
SGSushrima Gan
Sushrima Gan
RARanjit M. Anjana
Ranjit M. Anjana
EPEwan R. Pearson
Ewan R. Pearson
Aim: To conduct a comprehensive review of studies of glycaemic deterioration in type 2 diabetes and identify the major factors influencing progression.Methods: We conducted a systematic literature search with terms linked to type 2 diabetes progression. All the included studies were summarized based upon the factors associated with diabetes progression and how the diabetes progression was defined.Results: Our search yielded 2785 articles; based on title, abstract and full‐text review, we included 61 studies in the review. We identified seven criteria for diabetes progression: ‘Initiation of insulin’, ‘Initiation of oral antidiabetic drug’, ‘treatment intensification’, ‘antidiabetic therapy failure’, ‘glycaemic deterioration’, ‘decline in beta‐cell function’ and ‘change in insulin dose’. The determinants of diabetes progression were grouped into phenotypic, ethnicity and genotypic factors. Younger age, poorer glycaemia and higher body mass index at diabetes diagnosis were the main phenotypic factors associated with rapid progression. The effect of genotypic factors on progression was assessed using polygenic risk scores (PRS); a PRS constructed from the genetic variants linked to insulin resistance was associated with rapid glycaemic deterioration. The evidence of impact of ethnicity on progression was inconclusive due to the small number of multi‐ethnic studies.Conclusion: We have identified the major determinants of diabetes progression—younger age, higher BMI, higher HbA1c and genetic insulin resistance. The impact of ethnicity is uncertain; there is a clear need for more large‐scale studies of diabetes progression in different ethnic groups.

11 May 2017 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
SSS. Sumi
S. Sumi
SRSurya Ramachandran
Surya Ramachandran
VRV RamanKutty
V RamanKutty
MPMaulin Patel
Maulin Patel
TAT. N. Anand
T. N. Anand
CKCHANDRASEKHARAN CHERANELLORE KARTHA
CHANDRASEKHARAN CHERANELLORE KARTHA

6 February 2020 in BMC Public Health
Verified
Journal Article
Open access
PDF file
VKVijayakumar Krishnapillai
Vijayakumar Krishnapillai
SNSanjeev Nair
Sanjeev Nair
ANAnand T. N
Anand T. N
SPSreelal T. P
Sreelal T. P
BSBiju Soman
Biju Soman
Background: Kerala is facing challenges in the secondary prevention efforts of non-communicable diseases (NCDs). In spite of being the top performer in health parameters among Indian states, the burden of NCDs, especially diabetes mellitus (diabetes) and hypertension, is higher in Kerala. This research endeavours to identify the role of quality of medical prescriptions in secondary prevention of diabetes and hypertension and suggest corrective measures. Methods: This cross-sectional study involved collection of prescription data and other details from consenting doctors across seven districts in Kerala. After the quality of prescription was assessed using a checklist, scores were generated, and cutoff points were used to classify the prescriptions. PASW version 18 software, was used for data analysis which included univariate and bivariate analyses and logistic regression. The proportion of quality prescriptions was estimated after adjusting for clustering, and the proportion of doctors writing quality prescriptions was also estimated. Prior to the study, ethical clearance from Independent ethics committee in Health action by People (HAP) and informed consent from all the study participants were obtained. Results: After assessing 9199 prescriptions from 344 doctors, it was found that about 37.2% (95% CI: 34.9–39.4%) of the prescriptions were of good quality, and 48.2% (95% CI: 42.9–53.7%) of the doctors provided quality prescriptions. Factors associated with quality prescriptions were found to be knowledge about NCD guidelines, quality certifications of hospitals and usage of patient data management software. Conclusions: In the context of rising prevalence of NCDs and the challenges in the secondary prevention efforts, this is one of the first studies in Kerala to evaluate the quality of prescriptions to manage NCDs as prescriptions often reflect the quality of medical management. The study also addresses other factors associated with quality medical management. The findings indicate that the scope for improvement is more than 50%, when considered for the overall quality of prescriptions in diabetes and hypertension management. Further, it was found that appropriate training of doctors, adherence to treatment guidelines and the use of technology may improve the overall quality of prescriptions.

15 July 2025 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
EMElezebeth Mathews
Elezebeth Mathews
AJAnjaly Joseph
Anjaly Joseph
TAThakarakattil Narayanan Nair Anand
Thakarakattil Narayanan Nair Anand
BOBrian Oldenburg
Brian Oldenburg
KTKavumpurathu Raman Thankappan
Kavumpurathu Raman Thankappan
KNK M Venkat Narayan
K M Venkat Narayan

14 January 2026 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
EMElezebeth Mathews
Elezebeth Mathews
TAThakarakkattil Narayanan Nair Anand
Thakarakkattil Narayanan Nair Anand
AJAnjaly Joseph
Anjaly Joseph
BKBhagiaswari Kodapally
Bhagiaswari Kodapally
RPRajendra Pilankatta
Rajendra Pilankatta
KTKavumpurathu Raman Thankappan
Kavumpurathu Raman Thankappan